Significant progress in the battle against pancreatic cancer is emerging, thanks to a new medical breakthrough. An experimental drug, administered once daily, is showing potential in extending the lives of patients by slowing the advance of this highly lethal disease.
Dr. Rachna Shroff, who serves as the associate director of clinical investigations at the University of Arizona Comprehensive Cancer Center, discusses the promising outcomes with Stephanie Sy. The research indicates that this innovative treatment could represent a major step forward after years of dedicated study.
About Stephanie Sy
Stephanie Sy is currently a correspondent for PBS News Hour. She has extensive experience in journalism, having held positions as an anchor and correspondent for major networks including ABC News, Al Jazeera America, CBSN, CNN International, and PBS News Hour Weekend. Before her current role, she worked with Yahoo News where she covered the 2018 Midterm Elections and reported live from Donald Trump’s victory party on Election Day 2016.
Impact of Fake Smiles on Happiness 
Democratic Doctors and Scientists Enter Congress with New Agendas 
A Mother’s Journey with Her Newborn Son 
Experimental Heart Drug Fails to Meet Expectations in Crucial Study 
Popular Drinks Linked to Heart Attacks in Young Adults 
Illinois Faces Potential Ban on Hemp-Derived THC Products